In esophageal squamous cell carcinoma, downregulation of PLK1 can inhibit the pentose phosphate pathway, reduce NADPH and GSH levels, thereby promoting ferroptosis, and increasing the sensitivity of cancer cells to radiotherapy and chemotherapy (Zhao et al., 2023). This evidence concerns the gene PLK1 and esophageal squamous cell carcinoma.